
Novel STAT3 Inhibitor TT1-101 Is Safe and Shows Antitumor Activity in R/R HCC and Other Solid Tumors
Treatment with TT1-101, was well tolerated and showed clinically meaningful antitumor activity, including confirmed partial responses (cPRs), in patients with advanced metastatic hepatocellular carcinoma (HCC) and other solid tumors that were relapsed or …